ICEECE2012 Poster Presentations Diabetes (248 abstracts)
University of Brescia, Brescia, Italy
Preclinical and clinical studies suggest that whey protein intake can ameliorate postprandial glucose control and potentiate insulin release in both type-2 diabetic patients and healthy subjects.
Most likely, the insulinotropic effect of whey occurs by multiple pathways, including the potentiation of incretin activity through inhibition of DPP-4 in the proximal bowel, with the outcome of increasing intact incretin levels.
During last decades, it has been clearly shown that milk proteins, both caseins and whey proteins, are a source of short peptides with distinct biological activities which are generated by enzymatic hydrolysis during gastrointestinal digestion or during food processing.
Our aim was to identify DPP-4 inhibitors among short peptides occurring in hydrolysates of β-lactoglobulin, the major whey protein found in the milk of ruminants, by in silico and in vitro analysis.
The peptide Ile-Pro-Ala (IPA), called β-lactosin A have been previously identified in β-lactoglobulin hydrolysates prepared using proteinase K. We tested IPA in vitro for DPP-4 inhibitory activity, due to its structure similarity to the well-known inhibitor Ile-Pro-Ile. Although the substitution at position 3 resulted in a weakening of the inhibitory effect vs the reference compound Ile-Pro-Ile (IC50 value of 59 vs 7 μM), our results showed that the β-lactoglobulin-derived peptide IPA can be regarded as a moderate DPP-4 inhibitor.
Two more peptides (Leu-Leu and Leu-Ala) proved to act as DPP-4 inhibitors but their potency was tenfold lower as compared with IPA.
Based on in silico analysis of published β-lactoglobulin amino acid sequences, the peptide IPA is conserved across bovine, ovine and caprine species and within bovine variants but it is absent in β-lactoglobulin from donkey. More interestingly, our results suggest that the differential level of expression of β-lactoglobulin across and within species could significantly affect DPP-4 inhibitor content of whey.
Declaration of interest: The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research project.
Funding: This work was supported, however funding details unavailable.